首页> 美国卫生研究院文献>Mediators of Inflammation >Neutrophil-to-Lymphocyte Ratio Monocyte-to-Lymphocyte Ratio Platelet-to-Lymphocyte Ratio and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?
【2h】

Neutrophil-to-Lymphocyte Ratio Monocyte-to-Lymphocyte Ratio Platelet-to-Lymphocyte Ratio and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?

机译:中性粒细胞与淋巴细胞之比单核细胞与淋巴细胞之比血小板与淋巴细胞之比以及平均血小板体积与血小板计数之比作为重症患者和受伤患者的生物标志物:选择哪种比例来预测结果和病情细菌血症?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background Neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume-to-platelet count (MPV/PC) ratio are readily available parameters that might have discriminative power regarding outcome. The aim of our study was to assess prognostic value of these biomarkers regarding outcome in critically ill patients with secondary sepsis and/or trauma.
机译:背景中性粒细胞与淋巴细胞之比(NLR),单核细胞与淋巴细胞之比(MLR),血小板与淋巴细胞之比(PLR)以及平均血小板体积与血小板计数(MPV / PC)之比是容易获得的参数在结果方面可能具有判别力。我们研究的目的是评估这些生物标志物对继发性败血症和/或创伤的危重患者的预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号